The effect of alcohol use on IL-6 responses across different racial/ethnic groups

Future Virology

Volumn 7, Issue 2, 2012, Pages 205-213

  Míguez, María José ^a   Rosenberg, Rhonda ^a   Burbano Levy, Ximena ^a   Carmona, Talita ^a   Malow, Robert ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

AIDS; alcohol; HIV; IL 6; race ethnicity

Indexed keywords

INTERLEUKIN 6;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RESPONSE; ETHNIC AND RACIAL GROUPS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGRESSION ANALYSIS; VIRUS LOAD;

EID: 84856936981     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.3     Document Type: Article

References (32)

1. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011-1018 (1993). (Pubitemid 24035036)
2. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-534 (1996). (Pubitemid 26415922)
3. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin. Immunol. 5, 165-173 (1993).
4. Poli G, Fauci AS. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. In: Human Cytokines: Their Role in Disease and Therapy. Aggarwal BB, Puri RK (Eds). Blackwell Science, MA, USA, 421-449 (1995).
5. Poli G, Kinter AL, Fauci AS. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl Acad. Sci. USA 91, 108-112 (1994).
6. Zaitseva M, Lee S, Lapham C et al. Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection. Blood 96(9), 3109-3117 (2000).
7. Rodger AJ, Fox Z, Lundgren JD et al.; INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J. Infect. Dis. 200(6), 973-983 (2009).
8. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813(5), 878-888 (2011).
9. Marconi C, de Andrade Ramos BR, Peraçoli JC, Donders GG, da Silva MG. Amniotic fluid interleukin-1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor. Am. J. Reprod. Immunol. 65(6), 549-556 (2011).
10. Cussigh A, Falleti E, Fabris C et al. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics 63(1), 33-41 (2011).
11. Nishida H, Horio T, Suzuki Y et al. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein. Cytokine 53(3), 342-346 (2011).
12. SMART Study Group. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy. Ann. Int. Med. 149, 299-303 (2008).
13. Patanella AK, Zinno M, Quaranta D et al. Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients. J. Neurosci. Res. 88(5), 1106-1112 (2010).
14. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing Type 2 diabetes mellitus. JAMA 286, 327-334 (2001). (Pubitemid 32656163)
15. Amirayan-Chevillard N, Tissot-Dupont H, Capo C et al. Impact of highly active antiretroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin. Exp. Immunol. 120, 107-112 (2000). (Pubitemid 30176907)
16. Stone SF, Price P, Keane NM, Murray RJ, French MA. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med. 3(1), 21-27 (2002). (Pubitemid 34189592)
17. Neuhaus J, Jacobs DR, Baker JV et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J. Infect. Dis. 201, 1788-1795 (2010).
18. Dai J, Lin D, Zhang J et al. Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J. Clin. Invest. 106, 887-895 (2000).
19. Liu Y, Berthier-Schaad Y, Fallin MD et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J. Am. Soc. Nephrol. 17, 863-870 (2006).
20. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler. Thromb. Vasc. Biol. 22, 1668-1673 (2002).
21. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Sata F, Sato H. Effects of the interaction between interleukin-6 -634C/G polymorphism and smoking on serum C-reactive protein concentrations. Hypertens. Res. 30, 593-599 (2007). (Pubitemid 47278316)
22. Friedlander Y, Kark JD, Sinnereich R, Tracy RP, Siscovick DS. Fibrinogen and CRP in Israeli families, genetic and environmental sources of concentrations and longitudinal changes. Atherosclerosis 189, 167-177 (2006).
23. Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J. Clin. Invest. 118(4), 1244-1254 (2008). (Pubitemid 351500417)
24. Skinner HA, Allen BA. Alcohol dependence syndrome: measurement and validation. J. Abnorm. Psychol. 91, 199-209 (1982).
25. Szabo G, Mandrekar P, Catalano D. Inhibition of superantigen-induced T cell proliferation and monocyte IL-1 beta, TNF-alpha, and IL-6 production by acute ethanol treatment. J. Leukoc. Biol. 58, 342-350 (1995)
26. Deaciuc IV, Alappat JM, McDonougg KH, D'Souza NB. Effect of chronic alcohol consumption by rates on tumor necrosis factor-alpha and interleukin-6 clearance in vivo and by isolated, perfused liver. Biochem. Pharmacol. 52, 891-899 (1996). (Pubitemid 26301891)
27. Narkiewicz K, van de Borne PJ, Hausberg M et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 98, 528-534 (1998). (Pubitemid 28371250)
28. Stengel B, Couchoud C, Cénée S, Hémon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int. 57, 2519-2526 (2000). (Pubitemid 30340750)
29. Wesson DE. The relationship of cigarette smoking to end-stage renal disease. Semin. Nephrol. 23, 317-322 (2003). (Pubitemid 36841905)
30. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343, 1467-1476 (2000).
31. Te HS. Cholestasis in HIV-infected patients. Clin. Liver Dis. 8, 213-228, VIII-IX (2004). (Pubitemid 38373678)
32. Mandrekar P, Catalano D, Szabo G. Alcohol-induced regulation of nuclear regulatory factor kappa beta in human monocytes. Alcohol Clin. Exp. Res. 21, 988-994 (1997). (Pubitemid 27407159)